In the last decade, mitochondrial DNA (mtDNA) haplogroups have been associated with the occurrence of breast cancer. However, the underlying mechanism is not known. Combining a case-control study with a large cohort of women from Southern China with breast cancer and functional analyses with trans-mitochondrial technology, we demonstrate that the D5 haplogroup is associated with an increased risk of breast cancer [odds ratio (OR) 5 2.789; 95% confidence interval (CI) [1.318, 5.901]; p 5 0.007]. Furthermore, mitochondrial respiration, mitochondrial ATP content and membrane potential, were lower in both bone osteosarcoma and breast cancer cell models of cytoplasmic hybrids (cybrids) containing the mtDNA D5 haplogroup than in those with non-D5 haplogroups. Using in vitro and in vivo tumorigenicity assays, we found that cells with the D5 haplogroup were more susceptible to tumorigenesis compared to cells with non-D5 haplogroups. Mechanistically, the D5 haplogroup may promote tumorigenesis at least partially through activation of the v-AKT murine thymoma viral oncogene (AKT) via phosphorylation of threonine 308, which is mediated by increased reactive oxygen species generation in D5 cybrids. Our findings demonstrate that there is decreased mitochondrial function in cells with the D5 haplogroup compared to cells with non-D5 haplogroups, which may be associated with increased neoplastic growth in breast cancer.
In the last decade, mitochondrial DNA (mtDNA) haplogroups have been associated with the occurrence of breast cancer. However, the underlying mechanism is not known. Combining a case-control study with a large cohort of women from Southern China with breast cancer and functional analyses with trans-mitochondrial technology, we demonstrate that the D5 haplogroup is associated with an increased risk of breast cancer [odds ratio (OR) 5 2.789; 95% confidence interval (CI) [1.318, 5 .901]; p 5 0.007]. Furthermore, mitochondrial respiration, mitochondrial ATP content and membrane potential, were lower in both bone osteosarcoma and breast cancer cell models of cytoplasmic hybrids (cybrids) containing the mtDNA D5 haplogroup than in those with non-D5 haplogroups. Using in vitro and in vivo tumorigenicity assays, we found that cells with the D5 haplogroup were more susceptible to tumorigenesis compared to cells with non-D5 haplogroups. Mechanistically, the D5 haplogroup may promote tumorigenesis at least partially through activation of the v-AKT murine thymoma viral oncogene (AKT) via phosphorylation of threonine 308, which is mediated by increased reactive oxygen species generation in D5 cybrids. Our findings demonstrate that there is decreased mitochondrial function in cells with the D5 haplogroup compared to cells with non-D5 haplogroups, which may be associated with increased neoplastic growth in breast cancer.
The mitochondrial oxidative phosphorylation (OXPHOS) system contains five complexes that generate >90% of cellular ATP. 1 The system is under dual genetic control, of which four OXPHOS complexes are assembled with proteins encoded by both nuclear (nDNA) and mitochondrial DNA (mtDNA). Mutations in mtDNA have been reported in many human diseases, 2 and numerous mtDNA variants that occurred during selective events over the long period of human evolution are considered polymorphic sites. 3 A specific mtDNA haplogroup represents a set of single nucleotide polymorphisms (SNPs), which are genetically and statistically associated. Currently, it is understood that those adaptive mtDNA haplogroups, which originated in the past, can now be either advantageous or detrimental. 4 Different mtDNA haplogroups have been reported as protective or risk factors in a number of degenerative conditions. 5 Studies using cytoplasmic hybrids (cybrids), which are eukaryotic cell lines generated by the fusion of whole cells with cytoplasts, revealed that changes in mtDNA contents, mitochondrial RNA (mtRNA) levels, mitochondrial translational products and respiratory chain complexes assembly as well as mitochondrial biogenetic performances, such as ATP generation and mitochondrial membrane potential (MMP), in different mtDNA haplogroups contribute to the development of degenerative diseases. 6 It was found that changes caused by different mtDNA haplogroups in intracellular mitochondrial signals, such as mitochondrial matrix pH and intracellular calcium dynamics, 7 affected the expression of hundreds of nuclear genes related to specific diseases including age-related macular degeneration 8 and osteoarthritis. 9 Together, these results suggest that mtDNA haplogroups play a dual role in the pathogenesis of degenerative diseases. Breast cancer is one of the leading causes of cancer in women and studies have reported changes of mitochondrial function or intracellular mitochondrial signalling in breast cancer cells. 10, 11 In the past decade, multiple mtDNA haplogroups were identified and associated with breast cancer in different populations. 12, 13 Previously, haplogroup D5 was found to be a risk factor for multiple cancer types including breast cancer, 5, 14 although other studies found that D5 did not significantly contribute to predisposition to prostate cancer or breast cancer. 15, 16 To address these contradictory findings, and to better understand whether haplogroup D5 has a role in cancer occurrence, and in particular breast cancer, we aimed to elucidate the role of mtDNA haplogroup D5 in breast cancer at both the genetic and molecular levels using a case-control study with a large cohort of women with breast cancer from Southern China and functional analyses using trans-mitochondrial approaches.
Material and Methods

Subjects
In total, 296 female patients with histological confirmations of breast cancer [mean age (yr) 6 standard deviation (SD) of 50.09 6 10.03; median age 5 49, range were recruited in the First Affiliated Hospital of Wenzhou Medical College (Zhejiang, China) from August 2013 to August 2017. Furthermore, 636 geographically and gender-matched control subjects (mean age of 52.60 6 13.6; median age 5 53, range 17-92) with no history of cancer or other diseases known to be associated with mitochondrial defects were recruited at the Physical Examination Centre of the same hospital from July 2017 to August 2017. Informed consent were obtained from all patients and controls were applied according to the regulations set forth by the Ethics Committee of Wenzhou Medical University.
mtDNA copy number quantification
The ratio of mtDNA to nuclear DNA was determined to represent the relative copy number of mtDNA. Real-Time PCR reactions were performed on a Step One Real-Time PCR system (Thermo Fisher Scientific) using SYBRV R Green qPCR Mastermix (Takara Bio, Dalian, Liaoning, China). Primers were designed as follows: human mtDNA (human tRNA leucine 1 1 transcription terminator 1 5S-like sequence), 5 0 -CACCCAAGAACAGGGTTTGT-3 0 and 5 0 -TGGCCATGGG TATGTTGTTAA-3 0 ; and human nuclear DNA (18 sec ribosomal DNA), 5 0 -TAGAGGGACAAGTGGCGTTC-3 0 and 5 0 -CGCTGAGCCAGTCAGTGT-3 0 . The efficiencies of the primers were quantitatively determined to be between 90% and 110%.
Generation of cybrid and culture conditions
MDA-MB-231 cells lacking mtDNA were created by culturing them in the presence of 500 ng/mL ethidium bromide (EB) for approximately 2 months until mtDNA content was undetectable by the copy number quantification method (Supporting Information Figure S1A ). Trans-mitochondrial cybrids were obtained by fusing mtDNA-depleted human osteosarcoma 143B cells (gifted by Dr. Yidong Bai) or MDA-MB-231 cells with platelets containing haplogroup D5 (n 5 2) or non-D5 (n 5 2) (Supporting Information Figure  S1B and S2), as described previously. 17 All cells were cultured in high-glucose Dulbecco's Modified Eagles medium (DMEM) (HyClone, Waltham, MA) containing 10% Cosmic calf serum (Gibco, Carlsbad, CA).
mtDNA sequencing and genotyping
Genomic DNA was extracted from peripheral blood using an SDS lysis protocol. Two mtDNA regions of each subject were Sanger sequenced in cases and controls as described previously, 18 mtDNA haplogroups were annotated using MitoTool and manually checked according to published East Asian mtDNA tree. [19] [20] [21] Entire mtDNA genomes of cybrid cells were Sanger sequenced using 24 previously reported pairs of mtDNA primers. 22 SNPs of each subject were obtained by comparing the sequences with the revised Cambridge Reference Sequence (rCRS) using CodonCode Aligner 3.0.1 (CodonCode Corporation, Centerville, VA). Detailed mitochondrial DNA haplogroups were annotated using HaploGrep program (http://haplogrep.uibk.ac.at/) based on the entire mtDNA genome PhyloTree (http://www.phylotree.org).
In vitro tumorigenesis assay
A colony-forming assay was used to gauge tumorigenesis potential. Four thousand cells were cultured in 6-well plates ) were seeded in 6-well plates. The serum concentration was reduced to 5% and once cells reached approximately 80% confluence the medium was changed every 4 days. After 25 days, focus areas were photographed and analysed using Gel-Pro analyzer v4.0.
To measure wound healing, cells were cultured in 6-well plates to yield confluent monolayers. Wounds were introduced with a pipette tip and photographs were taken immediately (time zero), at 24 hr, 48 hr and 72 hr. The migration of cells into the wound area was quantified using Image J v2.4.1.7.
Mitochondrial protein preparation, blue native PAGE, western blot and respiratory complex enzymatic activity assay Mitochondrial membrane proteins were extracted with digitonin at a ratio of 6 g/g protein (Sigma, St. Louis, MO). Western blotting was performed as described elsewhere. 23 OXPHOS complexes were detected with anti-NDUFA13 (Grim19) (MitoSciences, Eugene, OR), anti-SDHA (MitoSciences), anti-Core2 (MitoSciences,), anti-COXI (MitoSciences) and anti-ATP synthase subunit alpha (MitoSciences) antibodies at a dilution of 1:1, 000. Enzyme activity was measured for four mitochondrial respiratory chain complexes in the mitochondria of cybrids as described previously. 24 
MMP, ATP and ROS measurements
MMP, mitochondrial reactive oxygen species (ROS) and ATP content were determined using the cationic fluorescent redistribution dye tetramethylrhodamine, methyl ester (TMRM) (Thermo Scientific, Waltham, MA), mitoSOX red (Molecular Probes, Carlsbad, CA) and an ATP measurement kit (Molecular Probes), respectively, according to the manufacturer's instructions. To measure the mitochondrial ATP content, cells were incubated with 5 lM antimycin A (Sigma) for 2 hr prior to measurement. Fluorescence/luminescence was monitored using a Varioskan TM Flash Multimode Reader (Thermo Scientific).
Oxygen consumption
Endogenous oxygen consumption from intact cells was determined using a Clark-type oxygen electrode (Oroboros Instruments, Innsbruck, Austria). 25 After recording basal respiration, oligomycin (2.5 lg/mL) (Sigma) and FCCP (0.25 lg/mL) (Sigma) were added to measure un-coupling and maximum respiration, respectively.
In vivo tumorigenesis assay
Approximately 4 3 10 6 143B and 2 3 10 6 MDA-MB-231 cells were injected subcutaneously into 6-week-old nu/nu female nude mice (SLRC Laboratory Animal Co., Shanghai, China). Three and half weeks following injection, mice were administered with 40 mM N-acetyl-L-cysteine (NAC, Sigma) daily via drinking water. Animals were observed regularly for tumour growth, survival, visible toxicity and changes in body weight. Tumour volume (mm 3 ), which was defined as (length 3 width 2 )/2, was calculated every 3-4 days with a calliper. After 8-9 weeks, all animals were sacrificed to measure the final tumour volume and tumour weight.
Statistical analysis
In case-control study, haplogroups with frequency > 5% in either the controls or breast cancer patients were analysed to evaluate the effect of common mtDNA haplogroup on breast cancer. Haplogroups G, M8a, M9, M10, M11 and R with frequencies of 2.4%, 3.7%, 0.3, 3.3%, 0.3% and 1% in patients; 2.7%, 2.2%, 0.3%, 1.2%, 0.4% and 2.8% in controls were assigned as 'Other haplogroups'. Multivariate logistic regression analysis was applied to adjust the risks associated with age and mtDNA haplogroups in breast cancer. Breast cancer was a dependent variable, and age and genotype of each mtDNA haplogroup were independent variables, of which dummy coding was applied in 9 mtDNA haplogroups due to their numerical variable property. In the analysis of the relations between cancer metastasis and mtDNA haplogroups, multivariate logistic regression analysis was applied to adjust the risk associated with status of progesterone receptor (PR) and oestrogen receptor (ER), age, and mtDNA haplogroups. Bonferroni correction indicating a p values < (0.05/9 5 0.006) was considered statistically significant while nine haplogroups (reference haplogroup and other haplogrups were excluded) were analysed in this study. A p values < (0.01/9 5 0.012) indicating a marginal significant. The significance of 'Other haplogroups' was not considered here because it contains multiple mtDNA haplogroups.
An independent Student's t test was used to evaluate cybrids data, and a null hypothesis was rejected when p < 0.05. All statistical analyses were carried out using SPSS 21.0 (IBM, Armonk, NY).
Results
Haplogroup D5 is associated with an increased risk of breast cancer
To determine the association between mtDNA haplogroup D5 and breast cancer, mtDNA haplogroups were annotated in 296 cases and 636 controls (Supporting Information Table  S1 ). As shown in Table 1 , we found an increased frequency of D5 [odds ratio (OR) 5 2.789; 95% confidence interval (CI) [1.318, 5 .901] in patients compared to controls using logistic regression analysis with adjustment for age and haplogroups. The risk effect of D5 in the occurrence of breast cancer was marginally significant, while the p values (0.007) is much closed to 0.006 (0.05/9 5 0.006) and lower than 0.012 (0.1/ 9 5 0.012). To evaluate whether the D5 haplogroup was associated with cancer metastasis in our patient cohort, multipleregression analysis was performed for 211 patients (the remainder were omitted from analysis due to incomplete medical records). After adjustment for clinical characteristics and mtDNA haplogroups, however, we did not find evidence of an association between mtDNA haplogroups and cancer metastasis evaluated in Table 2 .
Because previous reports showed that mtDNA haplogroups modulate mtDNA copy number, 18 ,26,27 we tested mtDNA copy number in patients with the D5 haplogroup versus non-D5 haplogroups. As shown in Supporting Information Figure S2 , we found that mtDNA copy number was significantly increased in a randomly selected subgroup of 58 patients with breast cancer compared to that found in 68 control subjects. However, we did not find any relationship between haplogroup D5 and mtDNA copy number in either patients or control subjects.
D5 cybrids have increased neoplastic activity
To investigate neoplastic activity in D5 cybrids, we performed several in vitro transformation assays to evaluate cancer cell reproductive viability, transforming potential and migration. We found that the number of colonies formed in 143B-D5 Cancer Epidemiology cybrids was 1.79-fold and 1.63-fold higher compared to A and D4 cybrids, respectively (Figs. 1a and 1b) . MDA-MB-231 D5 cybrid colony counts were 1.31-fold higher compared to non-D5 (A) cybrid (Figs. 1a and 1b) , although the rate of cell growth did not differ between D5 and non-D5 cybrids (Fig. 1c) . Furthermore, neither of the non-D5 cybrids readily formed foci compared to D5 cybrids (Figs. 1d and 1e) . Lastly, using a monolayer wound healing test with 143B cybrids, we found that cell migration increased 2.80-fold and 2.55-fold in D5 cybrids compared to A and D4 cybrids, respectively (Figs.  1f and 1g) . Similarly, MDA-MB-231 cells with the D5 haplogroup exhibited a 1.58-fold increase in cell movement compared to cells with a non-D5 haplogroup (Figs. 1h and  1i ). These findings illustrate that D5 cybrids have increased neoplastic activity and that the mtDNA D5 haplogroup may initiate a change in the cellular environment at a molecular level to predispose cells to tumour formation.
D5 cybrids have lower respiratory activity than non-D5 cybrids
To clarify the molecular effects of mtDNA haplogroup D5 on tumour formation, we first determined the mtDNA copy number between D5 and non-D5 cybrids. As shown in Supporting Information Figure S4A , mtDNA copy number was not significantly changed between D5 and non-D5 cybrids for both 143B and MDA-MB-231 cybrids. Consistently, we found that steady state levels of OXPHOS complexes were not affected in D5 cybrids compared to either A or D4 cybrids of 143B cells (Supporting Information Figure S4B ). However, endogenous basal respiration was 33% and 46% lower in haplogroup D5-containing 143B cybrids than A and D4 cybrids (Fig. 2a) , respectively. Although basal respiration was similar between D5 and non-D5 haplogroups, D5 cybrids exhibited 40% lower coupled mitochondrial respiration than A cybrids in breast cancer cells (Fig. 2b) . In 143B cells, D5 cybrids exhibited 47% and 67% lower coupled OXPHOS respiration compared to A and D4 cybrids (Fig. 2a) , respectively. Additionally, we found that the maximum respiratory capacity in D5 cybrids stimulated by FCCP was significantly lower than A and D4 cybrids in 143B cells (Figs. 2a and 2b) . To further clarify which component of the respiratory chain complexes contributes to the difference in mitochondrial respiration, we measured respiratory chain complex activity of D5 and non-D5 cybrids in both 143B and MDA-MB-231 cells. As shown in Figures 2c and 2d , the mean activity levels of complex I and III in D5 cybrids were lower than non-D5 cybrids in either 143B or MDA-MB-231 cells. Additionally, D5 and non-D5 cybrids from 143B and MDA-MB-231 cells displayed similar citrate synthase activity, indicating that mitochondrial mass as identical in these haplogroups (Figs. 2c and 2d) . Taken together, these observations indicate that the D5 haplogroup may reduce mitochondrial function by modulating the activity of respiratory chain complex I and complex III.
D5 cybrids have significantly lower mitochondrial function than non-D5 cybrids
Next, we measured mitochondrial MMP and ATP in haplogroup D5 and non-D5 osteosarcoma and breast cancer cybrids. The D5 haplogroup of 143B and MDA-MB-231 cybrids exhibited lower MMP than non-D5 (A and D4) 143B and non D5 (A) MDA-MB-231 cybrids (Fig. 2e) , respectively. Total ATP content was lower in the D5 haplogroup of 143B and MDA-MB-231 cybrids (Figs. 2f and 2g) . To investigate the contribution of mitochondrial OXPHOS on ATP production further, we blocked respiratory chain complex III by adding 5 lM Antimycin A to the culture medium. We found a 27% and 37% lower ATP content in D5-haplogroup 143B compared to A and D4 cybrids. Similarly, ATP content was 37% lower in D5-containing MDA-MB-231 cybrids compared to non-D5 (A) cybrids (Figs. 2f and 2g) . Collectively, our results indicate that a reduction in OXPHOS function may contribute to increased neoplastic activity found in D5 cybrids.
Haplogroup D5 and retrograde signalling
Previously, we confirmed that signals such as ROS can activate or suppress retrograde signalling pathways in the nucleus. 6 To ask if ROS plays a role in D5 related tumorigenesis, we measured mitochondrial ROS in cybrids. As shown in Figure 3a , ROS in the D5 cybrids was significantly higher than in the A and D4 cybrids of 143B cells (Fig. 3a) . The D5 cybrid from breast cancer cells also exhibited a higher level of ROS generation than the non-D5 cybrid (Fig. 3a) . We next evaluated the six major ROS-related mitochondrial related pathways, and found a higher level of AKT phosphorylation at Thr308, but not Ser473 in D5 cybrids compared to non-D5 cybrids in both 143B and MDA-MB-231 cybrids (Figs. 3b and 3c ). To determine whether elevated ROS generation in D5-containing cells was responsible for the over-phosphorylation of AKT, we used the antioxidant NAC, to scavenge ROS that had been produced in excess. As shown in Figure 3d , total levels of ROS decreased in cells treated with NAC for 2 hr. Accordingly, we found that increased AKT phosphorylation at Thr308 was reversed in both haplogroup D5-containing 143B and MDA-MB-231 cybrids following NAC treatment at different concentrations (Figs. 3e and 3f) . These results indicate that D5 cybrids exhibit lower OXPHOS function and promote ROS generation to over-phosphorylate AKT.
ROS scavenger alleviates tumorigenicity in D5 cybrids
To confirm that increased tumorigenicity in D5 cybrids was associated with ROS-induced AKT activation, we performed tumorigenicity assays in D5 cybrids with ROS scavenger. As shown in Figures 4a through 4d, colony formation (Figs. 4a  and 4b ) and cell migration (Figs. 4c and 4d ) in D5 MDA-MB-231 cybrids treated with NAC were similar to non-D5 (A) cybrid, and were less than D5 cybrid without NAC. To evaluate the impact of the mtDNA D5 haplogroup on tumour growth, and to determine whether NAC treatment can alleviate the increased tumorigenicity found in the D5 haplogroup, D5 and non-D5 (haplogroup A), cybrid cells were injected subcutaneously in nude mice. Both tumour size (Figs. 4e and 4f ) and tumour weight (Figs. 4g and 4h ) from (f) and (g) ATP content was measured in D5 and non-D5 cybrids of (f) 143B and (g) MDA-MB-231 cells (n 5 3). Antimycinresistant (A-resistant) ATP production was determined in cells treated with 5 lM antimycin for 2 hr, whereas antimycin-sensitive (A-Sensitive) ATP production was calculated by subtracting the A-resistant component from the total ATP content. The values of MMP and ATP were normalized to protein concentration. Base, basal OCR; Olig, OCR in the presence of 2.5 ug/mL oligomycin; FCCP, OCR in the presence of 0.25 ug/mL FCCP; Base-olig, oxidative phosphorylation associated with OCR was calculated by subtracting OCR in the presence of oligomycin from basal OCR. Data are expressed as the mean 6 SEM. *p < 0.05, **p < 0.01, ***p < 0.001. [Color figure can be viewed at wileyonlinelibrary.com] either 143B or MDA-MB-231 cybrids with haplogroup D5 were significantly higher than those found with haplogroup A, suggesting that D5 cybrids are susceptible to tumorigenesis. Importantly, tumorigenicity in D5 cybrid-containing mice administrated with NAC was comparable to that found with haplogroup A cybrids (Figs. 4e-4h ). Taken together, our findings support the proposal that the increased ROS level found in D5 cybrids promotes tumorigenesis.
Discussion
Macro-haplogroup M and its sibling haplogroup N originated from haplogroup L3 in Africa 6,000-to 7,000-years ago. Haplogroup M gave rise to sub-haplogroups, such as D, G and M8, of which haplogroup D is enriched in Central/East Asia, Siberia and America, with its highest frequency (26%) in East Asia. 28 Haplogroup D5 is one of the major subclades of haplogroup D with an estimated frequency between 3% and 10%, 19, 20 and was implicated as either a protective or a risk factor in multiple degenerative diseases. 29, 30 In this study, we confirmed that mtDNA haplogroup D5 is a risk factor for the occurrence of breast cancer (OR 5 2.789; 95%CI (1.318-5.901); p < 0.007), and such effect is related with ROSmediated AKT activation.
Due to in-proper use of statistical methods and some other questionable issues in previous published works, a reassessment of mtDNA haplogroups in the occurrence of breast cancer was made recently. 16 In our previous study, we found that haplogroup D5, which is a sub-haplogroup of the M macro-haplogroup, had a significantly higher frequency in patients with breast cancer compared to that found in control subjects (p 5 0.03). 5 Our conclusion was questioned because of limited sample size and lack of a validation cohort. 16 In this study, using different patient and control cohorts from southern China, here we independently confirmed that haplogroup D5 is a risk factor for the occurrence of breast cancer as statistically determined by a multivariate logistic regression analysis. Admittedly, we concur that the frequency of haplogroup D5 limited the fraction of breast cancer patients that were affected by it.
At the molecular level, two strategies were used to uncover the effects of mtDNA variants and/or haplogroups on human disease: the first is to deliver constructs with mtDNA sequence to model cells 31 ; the second is to use cybrid technology to transfer mitochondria into mtDNAdepleted nucleus donor cells. 6 Cybrid technology was developed several decades ago and was used extensively as a model to investigate the pathogenesis of various mtDNArelated human diseases, in which 143B osteosarcoma cell line was frequently used regardless of the cell type. 6, [32] [33] [34] Even in cancer studies, cybrids of 143B cells were adopted to investigate the underlying mechanism of mtDNA variants in prostate 35 and breast cancer. 36 Followed by cybrid technology, we used mtDNA-depleted 143B and MDA-MB-231 cells to study the effects of haplogroup D5 on breast cancer in this study. While some private variants such as m.14,487T > C may significantly affect the mitochondrial function, 37 we also sequenced the entire mitochondrial genomes to verify the existence of private mutation in the used cybrids (Supporting Information Table  S2 ). The only non-synonymous mutation in D5 cybrid mt.11,531G > A (named D5a2a) results in an alanine to threonine substitution in MT-ND4 (Supporting Information  Table S2 -2), which has been reported only once out of 32,059 complete mtDNA sequences in an mtDNA haplogroup M64. Evolutionary analysis showed that alternation of mt.11,531 is non-conserved (mtSNP database available at http://mtsnp.tmig.or.jp) (Supporting Information Figure S3 ), indicating that variation at mtDNA position 11,531 is likely a neutral mutation. Furthermore, recruitment of an additional D5 cybrid lacking the mt.11,531G > A mutation in this study allowed analysis of the functional differences of these cybrid cell lines at the haplogroup level. Therefore, the molecular mechanism of D5 on breast cancer can be elucidated by this solid cell model.
Mitochondrial OXPHOS dysfunction promotes neoplastic growth in multiple cancer cells. 10, 38 OXPHOS dysfunction facilitates cancer cell growth by shifting the balance of nutrition usage from catabolism to anabolism. 39, 40 On the other hand, OXPHOS dysfunction disturbs intracellular mitochondrial signals including ROS production, the ratio of AMP/ ATP, the NAD1/NADH ratio and calcium flux, through which cancer-related signalling pathways are abnormally induced. 41 The effects of mtDNA haplogroups on OXPHOS function have been reported frequently. 42, 43 Haplogroup D5 has been associated with an increased risk of oesophageal cancer 14 and the enrichment of longevity phenotype. 44 However, the underlying mechanism of the mtDNA haplogroup D5 in human disease is poorly understood. In cancer cells, decreased function but not severe impairment of the mitochondria is a marker of tumorigenesis. 45, 46 Previously, haplogroup D5 was associated with a significant decrease in complex I-dependent respiration compared to that of haplogroup D4a. 30 Similarly, we found that haplogroup D5 exhibited reduced mitochondrial OXPHOS function compared to that of the non-D5 haplogroups using multiple cybrid cell lines. We also found that among common Chinese mtDNA haplogroups, D5 displayed the lowest coupled mitochondrial respiration (unpublished data). Our biochemical investigation further demonstrated that the decreased OXPHOS performance associated with haplogroup D5 was because of not only lower complex I activity but also decreased complex III activity (Figs. 2c and 2d) . The steady state level of the OXPHOS complexes was not affected in cells with haplogroup D5, indicating there may be other changes such as kinetics that may have an overall effect on OXPHOS performance without altering the quantity. 42 Future studies are warranted to reveal the underlying mechanism fully. Consequently, MMP was significantly lower in cells with haplogroup D5 than those with non-D5 haplogroups, although the decrease was minor (Fig. 2e) . Notably, MMP was not differed between haplogroup D5 and D4 when using the fluorescent dye TMRE in another study, 30 which may be because TMRE artificially inhibits the electron transport chain. 47 Lastly, we investigated several mitochondrial-related signalling pathways and found that over-activation of AKT in haplogroup D5 cells may account for the observed neoplastic activity. Our results further indicate that over-activation of AKT was at least partially mediated by the increased ROS level found in cells with haplogroup D5. A limitation of this study is that a role for other signals, such as AMP/ATP, NAD1/NADH and calcium flux, cannot be excluded. Nevertheless, our findings are consistent with our previous findings that AKT over-activation is one of the retrograde signalling pathways that account for the elevated tumorigenesis in cells with decreased OXPHOS function. 38 Furthermore, we robustly confirmed that D5 cybrids have increased neoplastic activity and support the idea that decreased mitochondrial OXPHOS function may be responsible for the increased tumorigenesis observed in cells with the D5 haplogroup. In summary, we found that D5 haplogroup is a risk factor of breast cancer, and demonstrate that mtDNA haplogroup D5-expressing cells have increased ROS production, which may contribute to an increased risk of breast cancer tumorigenesis via AKT activation.
